Granted Patent
B2
US 10,875,837 · App. 16/279,904 · Granted Dec 29, 2020
Inhibitors of the fibroblast growth factor receptor
Inventors:
Neil Bifulco, Jr. (Sudbury, MA); Lucian V. DiPietro (Gloucester, MA); Brian L. Hodous (Arlington, MA); Chandrasekhar V. Miduturu (Cambridge, MA)
Assignee:
BLUEPRINT MEDICINES CORPORATION
C07D401/04C07D235/30C07D239/84C07D401/12C07D403/12C07D403/14C07D405/12C07D409/12C07D471/04C07D475/00
View Patent ↗
Loading inventors, assignments & file history…
Abstract
Described herein are inhibitors of FGFR-4, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions.
Claims (8)
1. A compound having the structure:
or a pharmaceutically acceptable salt thereof.
2. A compound having the structure:
or a pharmaceutically acceptable salt thereof.
3. The compound of claim 1 , wherein the compound is represented by:
4. A pharmaceutically acceptable salt of the compound of claim 1 .
5. The compound of claim 2 , wherein the compound is represented by:
6. A pharmaceutically acceptable salt of the compound of claim 2 .
Assignments (3)
RELEASE OF SECURITY INTEREST (REEL/FRAME NUMBER 060616/0923)
Recorded Jul 23, 2025
From: TAO TALENTS, LLC
To: BLUEPRINT MEDICINES CORPORATION
Reel/Frame 072193/0847 →
SECURITY INTEREST
Recorded Jul 8, 2022
From: BLUEPRINT MEDICINES CORPORATION
To: TAO TALENTS, LLC
Reel/Frame 060616/0923 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Feb 19, 2019
From: DIPIETRO, LUCIAN V.; HODOUS, BRIAN L.; MIDUTURU, CHANDRASEKHAR V.; BIFULCO, NEIL, JR
To: BLUEPRINT MEDICINES CORPORATION
Reel/Frame 048377/0378 →
Continuity (5)
Provisional Application
61927782
· Jan 15, 2014
Provisional Application
61895472
· Oct 25, 2013
Cited By (1)